Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine - Test2 - elhamkhani - TriplyDB

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

http://www.wikidata.org/entity/Q24646217

about

Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development Common stemness regulators of embryonic and cancer stem cells A mechanical biomarker of cell state in medicine Stem cell-based approach for the treatment of Parkinson's disease Regenerative medicine in urology Mesenchymal stem cell secretome and regenerative therapy after cancer A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers.Direct optical activation of skeletal muscle fibres efficiently controls muscle contraction and attenuates denervation atrophy Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma Metabolic control of cancer cell stemness: Lessons from iPS cells Stem cell applications for pathologies of the urinary bladder The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis Technology advancement for integrative stem cell analyses Identification of DPPA4 and DPPA2 as a novel family of pluripotency-related oncogenes.Pluripotent transcription factors possess distinct roles in normal versus transformed human stem cells.Transcriptional regulatory networks underlying the reprogramming of spermatogonial stem cells to multipotent stem cells.Stem cell therapies for the treatment of radiation-induced normal tissue side effects.Human stem cells for craniomaxillofacial reconstruction.Directed embryonic stem cell differentiation with small molecules.Elimination of undifferentiated human embryonic stem cells by cardiac glycosides.Natural immunity to pluripotency antigen OCT4 in humans.Immunity to stemness genes in human cancer.An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells.Self-Destruct Genetic Switch to Safeguard iPS Cells.Induction of multipotency in umbilical cord-derived mesenchymal stem cells cultivated under suspension conditions.Stem cell bioprocess engineering towards cGMP production and clinical applications Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges.Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton Building muscle: molecular regulation of myogenesis.Role of liver stem cells in hepatocarcinogenesis.Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells.Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective.Could cord blood cell therapy reduce preterm brain injury?Inhibition of pluripotent stem cell-derived teratoma formation by small molecules In vivo conversion of astrocytes to neurons in the injured adult spinal cord Time to reconsider stem cell induction strategies Present state and future perspectives of using pluripotent stem cells in toxicology research

P2860

Q26745715-A6828450-34C1-4471-976F-B8700F950DD7 Q26772879-8F3F3A3D-B81C-4D22-94A5-CA4CC4BFBC9A Q26773466-0366CCBC-D96D-468B-A996-7105AF552FB8 Q26777882-E3F4F32C-62D8-4067-A7A2-853E04E6F44F Q26851354-9955C4CB-F517-4CC3-8D41-8B958ECEF970 Q27004330-B7326432-0B83-40BD-9519-C3755D1CAB5A Q27006859-F33EF0A6-543B-447F-B88D-07305EEB88BA Q27007499-288E3898-823B-407D-8AFA-17E082F8896D Q27315819-11C5E152-5CA2-472E-A003-6B0A307C6D4C Q27321734-8F89624B-A64E-4853-B318-11D053DAAF9B Q27693217-0841B837-1963-4451-BBE3-D7511CABC51F Q28069546-A0085DDB-7256-4753-859F-10471E4C37DC Q28081608-88021610-D7A5-4DC7-B103-1967F96D0C5B Q28085228-F703EDEA-8E21-4BE2-B4D4-3125C490C1F2 Q28119042-167BA346-A9C6-493D-AF21-77974C4A1111 Q30397631-2A6F57D2-3632-4DB1-843B-92E099AF1E49 Q30662635-37779C0A-0F89-42B7-AC30-08F098D7650E Q30942937-B4B637A8-A445-4CDC-BCF8-7E56D937F82C Q33646212-A8F16E0A-2E08-4E8F-9515-5518AD658334 Q33768112-B14C7ADC-AA9A-47C3-A77F-80EF255338E9 Q33788845-C5C3AFDB-ACB4-401F-ADDA-564CFD160E2B Q33852431-414F3B18-1377-4D8F-AB9F-044B73710EE3 Q33902853-D72C7511-F4E4-47D0-80FE-3F673BCE41AF Q33928635-990F200D-D838-40E9-A1F9-742DDE81EDE7 Q33943241-4AA72499-52BE-4044-82F0-A50410426E44 Q34044130-A6BE9A04-A770-4822-B34A-5FF3CA903436 Q34044765-85CD6E8D-E336-4C08-B6C4-475F54C15340 Q34099882-A5415622-6F7C-4614-97C5-4AE3AFD75BDA Q34150828-7F40798A-D969-42F5-B6C3-6300074A7812 Q34151620-CD2ABFFC-5317-465A-B720-4FC112BCCAE0 Q34159047-338C687E-8EEC-4210-A6DB-29AF7CF4D291 Q34251533-ED638094-F5CF-403E-A28A-1C10E3D5B8B1 Q34259112-75B67165-00ED-4A20-9231-10DFA9B9A77F Q34278003-CC5E7A59-3651-434D-BECE-04CDFDEB3193 Q34306425-2FA0F737-9233-4AB4-856C-D7036F034F81 Q34312137-8B7351BC-53B0-486E-A405-5DCECD03A01F Q34362039-99999F6C-FD77-4282-82E5-CAC8ABCBC01F Q34406755-B80201DA-D438-47F2-BB30-559815AD7585 Q34414126-3842BB53-850D-4F89-B810-128621EF178D Q34520935-231CC116-D3D8-483B-B666-B14F1406508F

P2860

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

http://www.wikidata.org/entity/Q24646217

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@ast

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@en

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@nl

type

label

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@ast

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@en

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@nl

prefLabel

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@ast

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@en

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@nl

P1433

Q24646217-DB8E2118-1828-4855-8762-ED5642C4F1EC

P1476

Q24646217-5800DB39-C5A6-4DFC-8863-66819CB130DE

P2093

Q24646217-A14ABEFA-DB05-4DDB-BB35-AD8B401DCA48

P275

Q24646217-60ACC2F7-EFEE-4AE5-B836-9DC615AD3F01

P2860

Q24646217-0D9B3DD6-2041-4997-AFFC-BD11F4382216

Q24646217-14C228A4-8443-4163-8E9B-E03BC313B58E

Q24646217-1A11B63B-7B66-46E7-A328-7ED53A898568

Q24646217-2115E916-40DF-4945-8D8F-CC5AD1D51E1A

Q24646217-22E34F28-CCD5-46D1-9290-7121400FDB91

Q24646217-247DB336-A263-478D-8D67-E024ADEB92E7

Q24646217-28D3899A-28FE-40B7-868B-CB96A375D628

Q24646217-2AD9E4C0-6766-42D9-A9E3-6396D8CAFE6E

Q24646217-31E5E93D-E68E-4500-804B-2A335D1BEB5A

Q24646217-36FF373E-0723-4B6D-8E37-63759256FED1

P304

Q24646217-7D2BBC2B-12D0-4EED-A87E-6E45F49A56AF

P31

Q24646217-896084B3-F975-4AAB-8E6E-393A6D40B97F

Q24646217-AF1E88DD-63A1-42CE-87A3-4011019C499F

P3181

Q24646217-CA125CD5-BCF4-4D9F-A03E-7869C732606D

P356

Q24646217-4874EEBC-7544-4F78-B975-608C759CEA3D

P407

Q24646217-0B94C84B-DE45-488D-9191-37C151BA1A23

P433

Q24646217-4A9E99F8-0669-4A36-B5D8-071CCB47D164

P478

Q24646217-EC1D2C16-211A-496A-A2E8-C138E17603DD

P577

Q24646217-15EA70AC-5038-4EBD-AEE7-ED948F331508

Q24646217-4ECE8DA8-B708-4443-9B25-7AB52E8E34F6

P5875

Q24646217-D3C20C98-A491-4C0F-A93F-F0022FA2DBFC

P698

Q24646217-5EBA3C5E-FECE-48EA-BFA2-153923C17399

P921

Q24646217-A634F78E-D7AA-48F5-8A4B-A7F21B75A611

Q24646217-C14D3E40-D30D-4D0B-A450-CC5C223B8166

P932

Q24646217-88ACE044-9572-4BAE-B325-CD47B93FB85D

P3181

P356

P1433

P1476

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

@en

P2093

Paul S Knoepfler

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

Induced pluripotent stem cell lines derived from human somatic cells

Establishment in culture of pluripotential cells from mouse embryos

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

Generation of germline-competent induced pluripotent stem cells

N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

P304

1050-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1512693

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/STEM.37

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24402023

http://www.w3.org/2001/XMLSchema#string

P698

19415771

http://www.w3.org/2001/XMLSchema#string

P921

P932

2733374

http://www.w3.org/2001/XMLSchema#string